Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Visa
V
|
+$2.17B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.84B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 4 |
Linde
LIN
|
+$743M |
| 5 |
DuPont de Nemours
DD
|
+$592M |
Top Sells
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.5B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$311M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$281M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
IAC Inc
IAC
|
+$239M |
Sector Composition
| 1 | Technology | 17.81% |
| 2 | Financials | 12.09% |
| 3 | Healthcare | 10.06% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$4.69B
| $236K | ﹤0.01% |
4,269
-3,000
| -41% | -$166K |
|
2602
First Foundation Inc
FFWM
$489M
| $236K | ﹤0.01% |
18,042
-5,374
| -23% | -$70.3K |
|
2603
Albertsons Companies
ACI
$10.3B
| $235K | ﹤0.01% |
16,987
-2,898
| -15% | -$40.1K |
|
2604
Celestica
CLS
$28.6B
| $235K | ﹤0.01% |
+34,100
| New | +$235K |
|
2605
Hooker Furnishings Corp
HOFT
$108M
| $234K | ﹤0.01% |
9,080
-10,374
| -53% | -$267K |
|
2606
Dianthus Therapeutics
DNTH
$1.47B
| $233K | ﹤0.01% |
2,151
+788
| +58% | +$85.4K |
|
|
SAGE
2607
DELISTED
Sage Therapeutics
SAGE
| $233K | ﹤0.01% |
3,806
-14,050
| -79% | -$860K |
|
|
MCBC
2608
DELISTED
Macatawa Bank Corp
MCBC
| $233K | ﹤0.01% |
35,670
-2,401
| -6% | -$15.7K |
|
2609
Shore Bancshares
SHBI
$569M
| $232K | ﹤0.01% |
21,206
+5,375
| +34% | +$58.8K |
|
2610
Ocular Therapeutix
OCUL
$2.18B
| $231K | ﹤0.01% |
30,447
+876
| +3% | +$6.65K |
|
2611
Bally's
BALY
$491M
| $230K | ﹤0.01% |
8,745
-18,094
| -67% | -$476K |
|
|
TECX
2612
Tectonic Therapeutic, Inc. Common Stock
TECX
$310M
| $230K | ﹤0.01% |
1,476
-257
| -15% | -$40K |
|
|
CBAY
2613
DELISTED
Cymabay Therapeutics
CBAY
| $230K | ﹤0.01% |
31,739
-87,062
| -73% | -$631K |
|
|
ATRS
2614
DELISTED
Antares Pharma, Inc.
ATRS
| $230K | ﹤0.01% |
85,220
-14,994
| -15% | -$40.5K |
|
2615
Geron
GERN
$810M
| $229K | ﹤0.01% |
131,556
-9,235
| -7% | -$16.1K |
|
2616
Mitek Systems
MITK
$455M
| $229K | ﹤0.01% |
17,991
-3,674
| -17% | -$46.8K |
|
2617
Stoke Therapeutics
STOK
$1.28B
| $229K | ﹤0.01% |
6,815
-3,166
| -32% | -$106K |
|
|
UMH
2618
UMH Properties
UMH
$1.28B
| $229K | ﹤0.01% |
16,830
-3,345
| -17% | -$45.5K |
|
|
RETA
2619
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $229K | ﹤0.01% |
2,343
-17,586
| -88% | -$1.72M |
|
|
SABA
2620
Saba Capital Income & Opportunities Fund II
SABA
$254M
| $228K | ﹤0.01% |
18,506
+1,672
| +10% | +$20.6K |
|
2621
Tootsie Roll Industries
TR
$2.99B
| $228K | ﹤0.01% |
8,547
-2,052
| -19% | -$54.7K |
|
|
TGP
2622
DELISTED
Teekay LNG Partners L.P.
TGP
| $228K | ﹤0.01% |
21,696
+1,454
| +7% | +$15.3K |
|
2623
Ennis
EBF
$465M
| $227K | ﹤0.01% |
13,038
-2,367
| -15% | -$41.2K |
|
2624
Surgery Partners
SGRY
$2.77B
| $226K | ﹤0.01% |
10,311
-2,181
| -17% | -$47.8K |
|
2625
Ollie's Bargain Outlet
OLLI
$8.35B
| $225K | ﹤0.01% |
2,574
-31,784
| -93% | -$2.78M |
|